These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27002762)

  • 1. Elevated serum levels of MMP-11 correlate with poor prognosis in colon cancer patients.
    Pang L; Wang DW; Zhang N; Xu DH; Meng XW
    Cancer Biomark; 2016 Mar; 16(4):599-607. PubMed ID: 27002762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
    Jiang T; Xie P; Liu H
    J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy.
    Szarvas T; Becker M; Vom Dorp F; Meschede J; Scherag A; Bánkfalvi A; Reis H; Schmid KW; Romics I; Rübben H; Ergün S
    Int J Cancer; 2011 Mar; 128(6):1486-92. PubMed ID: 20473942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma.
    Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S
    Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative serum levels of matrix metalloproteinase-2 (MMP-2) and survival of breast cancer among Korean women.
    Song N; Sung H; Choi JY; Han S; Jeon S; Song M; Lee Y; Park C; Park SK; Lee KM; Yoo KY; Noh DY; Ahn SH; Lee SA; Kang D
    Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1371-80. PubMed ID: 22634108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
    Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
    Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of serum matrix metalloproteinase-13 levels in patients with esophageal squamous cell carcinoma (ESCC).
    Jiao XL; Chen D; Wang JG; Zhang KJ
    Eur Rev Med Pharmacol Sci; 2014; 18(4):509-15. PubMed ID: 24610617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-9 overexpression is closely related to poor prognosis in patients with colon cancer.
    Yang B; Tang F; Zhang B; Zhao Y; Feng J; Rao Z
    World J Surg Oncol; 2014 Jan; 12():24. PubMed ID: 24476461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.
    Wu ZS; Wu Q; Yang JH; Wang HQ; Ding XD; Yang F; Xu XC
    Int J Cancer; 2008 May; 122(9):2050-6. PubMed ID: 18172859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of interleukine-8 as an independent prognostic factor for sporadic colon cancer dissemination.
    Nastase A; Paslaru L; Herlea V; Ionescu M; Tomescu D; Bacalbasa N; Dima S; Popescu I
    J Med Life; 2014 Jun; 7(2):215-9. PubMed ID: 25408728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of combined detection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis.
    Zhang W; Yang HC; Wang Q; Yang ZJ; Chen H; Wang SM; Pan ZM; Tang BJ; Li QQ; Li L
    Anticancer Res; 2011 Oct; 31(10):3423-8. PubMed ID: 21965756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High level of plasma matrix metalloproteinase-11 is associated with clinicopathological characteristics in patients with oral squamous cell carcinoma.
    Hsin CH; Chen MK; Tang CH; Lin HP; Chou MY; Lin CW; Yang SF
    PLoS One; 2014; 9(11):e113129. PubMed ID: 25423087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of matrix metalloproteinase-1 levels in peripheral plasma and tumour tissues of lung cancer patients.
    Li M; Xiao T; Zhang Y; Feng L; Lin D; Liu Y; Mao Y; Guo S; Han N; Di X; Zhang K; Cheng S; Gao Y
    Lung Cancer; 2010 Sep; 69(3):341-7. PubMed ID: 20060194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma MMP-1 Expression as a Prognostic Factor in Colon Cancer.
    Jonsson A; Falk P; Angenete E; Hjalmarsson C; Ivarsson ML
    J Surg Res; 2021 Oct; 266():254-260. PubMed ID: 34034060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal mucosal MMP-1 - a prognostic factor in colon cancer.
    Langenskiöld M; Ivarsson ML; Holmdahl L; Falk P; Kåbjörn-Gustafsson C; Angenete E
    Scand J Gastroenterol; 2013 May; 48(5):563-9. PubMed ID: 23485198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-9 is associated with relapse and prognosis of patients with colorectal cancer.
    Chu D; Zhao Z; Zhou Y; Li Y; Li J; Zheng J; Zhao Q; Wang W
    Ann Surg Oncol; 2012 Jan; 19(1):318-25. PubMed ID: 21455597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low serum MMP-1 in breast cancer: a negative prognostic factor?
    Kulić A; Dedić Plavetić N; Vrbanec J; Sirotković-Skerlev M
    Biomarkers; 2012 Aug; 17(5):416-21. PubMed ID: 22515421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.